Endonovo Therapeutics, Inc. Financial Ratios — ENDV Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-16.2	-357.3	-3,813.99	-1,610.13	-2,974.26	-1,460.27	-438.46	-145.37	-460.68	-13.45	-134.58	-1,123.61	721.56	-853.09
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-39.02	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	- -	38.88	35.99	49.31	- -	- -	84.47	69.89	60.57	79.5	92.62	94.41	33.2
EBITDA Margin (%)	-111.64	2.05	- -	-10,555.39	-8,992.54	-59,786.35	- -	- -	-4,214.41	-1,018.42	-1,363.69	-2,158.61	-1,933.75	-1,620.44	-9,373.7
Operating Margin (%)	-113.23	- -	- -	-10,607.65	-9,057.59	-60,132.73	- -	- -	-4,995.33	-1,228.08	-1,756.49	-3,045.68	-2,411.69	-2,081.72	-15,532.54
Incremental Operating Margin (%)	- -	-535.18	3,636.26	- -	- -	- -	66,735.33	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-113.23	-195.3	- -	-12,632.17	-3,966.16	-158,633.9	- -	- -	-7,729.53	-5,582.37	-238.6	-4,247.17	-13,649.17	4,937.6	-27,853.2
Profit Margin (%)	-114.55	-196.97	- -	-12,634.5	-3,966.16	-158,633.9	- -	- -	-7,729.53	-5,582.37	-238.6	-4,247.17	-13,649.17	4,937.6	-27,853.2
Net Income to Common Margin (%)	-114.55	-196.97	- -	-12,634.5	-3,966.16	-158,633.9	- -	- -	-7,729.53	-5,582.37	-238.6	-4,247.17	-13,649.17	4,937.6	-27,853.2
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	- -	1	- -	1	1	2	2	5	13	7	7	7	7	7	7
ST Debt	- -	- -	- -	1	1	2	2	5	6	7	7	7	7	7	7
LT Debt	- -	1	- -	- -	- -	- -	- -	- -	6	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	1,189.99	-0.17	-0.31	-0.65	-0.61	-0.38	-1.03	-3.6	-2.17	-2.93	-4.55	-2.73	-3.11	-7.3
Net Debt/EBITDA	0.51	1,180.34	-0.17	-0.31	-0.65	-0.6	-0.37	-1.01	-3.5	-2.17	-2.93	-4.5	-2.73	-3.11	-7.3
Total Debt/EBIT	- -	- -	-0.17	-0.31	-0.65	-0.61	-0.38	-1.03	-3.04	-1.8	-2.28	-3.23	-2.19	-2.42	-4.4
Net Debt/EBIT	0.51	- -	-0.17	-0.31	-0.65	-0.59	-0.37	-1.01	-2.95	-1.8	-2.27	-3.19	-2.19	-2.42	-4.4
EBITDA to Interest Expense	- -	- -	-14.97	-9.03	-12.16	- -	- -	- -	-0.68	-0.52	-1.09	-1.68	-1.98	-1.77	-0.76
EBITDA-CapEx/Interest Expense	- -	- -	-16.11	-9.03	-12.16	- -	- -	- -	-0.68	-0.52	-1.09	-1.68	-1.98	-1.77	-0.76
EBIT to Interest Expense	- -	- -	-15.3	-9.08	-12.25	- -	- -	- -	-0.8	-0.63	-1.4	-2.36	-2.47	-2.28	-1.26
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	5	6	2	1	1	1	1
Common Equity/Total Assets	98.87	-45.01	-2,408.62	-5,614.95	-10,294.16	-2,265.97	-2,686.67	-207.06	-268.53	-626.14	-551.35	-785.88	-2,511.61	-3,778.17	-151,274.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	104.49	-3.24	-1.26	-0.87	-0.57	-0.06	- -	503.15	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	75.49	66.14	57.6	62.84	10.81	1.32	- -	149.08	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	-260.49	-15.29	-18.32	-30.16	-16.85	-24.12	-49.58	-111.03	-33.47	-46.15	-45.52	-22.23	-29.34	-25.63
Total Debt/Capital (%)	- -	162.31	-18.05	-22.42	-43.18	-20.27	-31.78	-98.35	1,006.29	-50.3	-85.71	-83.57	-28.58	-41.52	-34.46
Total Debt/Total Assets (%)	- -	117.25	368.31	1,028.48	3,104.58	381.83	647.9	102.67	298.16	209.55	254.47	357.77	558.3	1,108.44	38,769.79
Net Debt to Equity	-20.94	-258.38	-15.25	-18.24	-30.14	-16.4	-23.47	-48.64	-107.71	-33.38	-46.06	-44.98	-22.23	-29.33	-25.63
Net Debt/Capital (%)	-26.49	163.14	-17.99	-22.31	-43.14	-19.62	-30.66	-94.7	1,397.75	-50.09	-85.39	-81.75	-28.58	-41.5	-34.46
EBITDA	- -	- -	-2	-2	-2	-3	-5	-5	-4	-3	-2	-2	-3	-2	-1
EBITDA-CapEx	- -	- -	-2	-2	-2	-3	-5	-8	-4	-3	-2	-2	-3	-2	-1
Operating Income (Loss)	- -	- -	-2	-2	-2	-3	-5	-5	-4	-4	-3	-2	-3	-3	-2

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	- -	0.01	- -	- -	- -	- -	0.01	0.01	0.02	- -	- -	- -	- -	- -	- -
Current Ratio	- -	0.01	- -	- -	- -	0.04	0.03	0.01	0.02	- -	- -	0.01	- -	- -	- -
Quick Ratio	- -	0.02	- -	- -	- -	- -	0.01	0.01	0.02	- -	- -	- -	- -	- -	- -
CFO/Avg Current Liab	- -	-0.15	-0.23	-0.09	-0.21	-0.15	-0.27	-0.27	-0.2	-0.13	-0.04	-0.06	-0.03	- -	- -
Common Equity/Total Assets	98.87	-45.01	-2,408.62	-5,614.95	-10,294.16	-2,265.97	-2,686.67	-207.06	-268.53	-626.14	-551.35	-785.88	-2,511.61	-3,778.17	-151,274.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	104.49	-3.24	-1.26	-0.87	-0.57	-0.06	- -	503.15	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	75.49	66.14	57.6	62.84	10.81	1.32	- -	149.08	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	-260.49	-15.29	-18.32	-30.16	-16.85	-24.12	-49.58	-111.03	-33.47	-46.15	-45.52	-22.23	-29.34	-25.63
Total Debt/Capital (%)	- -	162.31	-18.05	-22.42	-43.18	-20.27	-31.78	-98.35	1,006.29	-50.3	-85.71	-83.57	-28.58	-41.52	-34.46
Total Debt/Total Assets (%)	- -	117.25	368.31	1,028.48	3,104.58	381.83	647.9	102.67	298.16	209.55	254.47	357.77	558.3	1,108.44	38,769.79
CFO/Total Liabilities	447.47	-3.49	-14.26	-6.12	-19.19	-10.52	-27.73	-21.11	-18.41	-10.69	-4.37	-5.55	-2.03	0.49	0.37
CFO/CapEx	51.22	- -	-2.17	- -	- -	-266.21	- -	-1	-320.98	-979.57	- -	- -	- -	- -	- -
Altman's Z-Score	-5.08	-159.5	-143.97	-329.01	-458.26	-89.69	-168	-640.8	-209.42	-1,674.28	-2,182.53	-1,132.46	-9,849.69	-6,882.95	-7,712.11

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	- -	4.77	- -	- -	- -	- -	- -	- -	49.78	23.78	14	77.52	286.77	- -	- -
Days Sales Outstanding	- -	76.58	- -	- -	- -	- -	- -	- -	7.33	15.35	26.07	4.71	1.27	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	0.09	0.1	0.01	- -	- -	0.09	0.25	0.1	0.02	0.01	0.01	- -
Accounts Payable Turnover Days	- -	- -	- -	4,043.09	3,653.54	26,167.9	- -	- -	4,253.31	1,479.11	3,630.52	16,555.86	28,181.69	45,784.06	122,748.84
Cash Conversion Cycle	- -	- -	- -	-4,043.09	-3,653.54	-26,167.9	- -	- -	-4,245.98	-1,463.76	-3,604.45	-16,551.15	-28,180.42	-45,784.06	-122,748.84
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	7.33	15.35	26.07	4.71	1.27	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	- -	- -	- -	- -	102	38	7	18	8	2	- -	1	4	3	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	- -	1	1	2	2	5	13	7	7	7	7	7	7
Enterprise Value	- -	1	1	1	103	39	9	23	20	9	7	8	11	10	7
Total Capital	- -	1	-2	-3	-3	-8	-6	-5	1	-14	-8	-9	-25	-17	-20
Total Debt/Capital (%)	- -	162.31	-18.05	-22.42	-43.18	-20.27	-31.78	-98.35	1,006.29	-50.3	-85.71	-83.57	-28.58	-41.52	-34.46
Total Debt / EV	- -	1.01	0.51	0.97	0.01	0.04	0.24	0.21	0.63	0.75	0.93	0.87	0.65	0.72	0.97
EV/Sales	- -	24.19	- -	34.04	4,265.69	9,205.43	- -	- -	241.58	29.35	42.91	112.95	81.2	70.19	705.68
EV/EBITDA	- -	1,180.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	76.34	- -	- -	- -	- -	8.68	2.56	5.3	- -	17.1	7.01	5.3
EV/Free Cash Flow to Firm	- -	- -	- -	76.34	- -	- -	- -	2,251.06	8.64	2.56	5.3	- -	17.1	7.01	5.3
Diluted Market Cap	- -	- -	- -	- -	38	35	6	14	7	1	- -	1	3	2	- -
Diluted Enterprise Value	- -	1	1	1	39	36	8	19	19	8	7	8	10	9	7
EV per Share	- -	2,490.42	1,045.18	936.81	1,267.37	374.62	64.86	72.66	46.66	7.65	0.29	0.11	0.05	0.03	0.01
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	-2	-2	-2	-3	-5	-5	-4	-3	-2	-2	-3	-2	-1
TTM Operating Income	- -	- -	-2	-2	-2	-3	-5	-5	-4	-4	-3	-2	-3	-3	-2
TTM Cash Flow to Firm	- -	- -	- -	- -	-1	-1	-2	-3	2	4	1	- -	1	1	1
TTM Free Cash Flow to Firm	- -	- -	- -	- -	-1	-1	-2	- -	2	4	1	- -	1	1	1

Multiples (USD)

Valuation Multiples API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	- -	- -	-1.82	-0.1	-41.64	-34.34	-2.38	1,372.55	-2.3	-0.52	-0.33	-0.95	-3.69	19.73	2.16
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	1	1	1	103	39	9	23	20	9	7	8	11	10	7
Low Price	- -	- -	510	25	31	52	15.1	9.2	15	1.1	0.02	0.01	- -	0.01	- -
EV/Sales	- -	24.19	- -	34.04	4,265.69	9,205.43	- -	- -	241.58	29.35	42.91	112.95	81.2	70.19	705.68
EV/EBITDA	- -	1,180.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.35	- -
Price/Earnings Average	- -	- -	-0.14	-0.02	-43.05	-9.15	-5.93	-1.04	-2.21	-0.52	-9.66	-0.61	-0.09	0.54	-0.43
Price/Earnings High	- -	- -	-0.14	-0.15	-167.62	-17.89	-19.33	-3.05	-3.72	-1.65	-120.43	-1.93	-0.19	1.12	-2.61
Price/Earnings Low	- -	- -	-0.14	-0.01	-0.98	-0.74	-0.33	-0.21	-0.84	-0.04	-0.62	-0.27	-0.01	0.28	-0.08
Price/Book Value	- -	- -	-0.15	-0.01	-21.69	-4.07	-0.78	-1.92	-0.69	-0.11	-0.03	-0.07	-0.12	-0.12	-0.01
Price/Book Value Average	- -	- -	-0.15	-0.01	-23.66	-7.22	-4.21	-1.54	-1.48	-0.75	-0.53	-0.15	-0.08	-0.18	-0.04
Price/Book Value High	- -	- -	-0.15	-0.1	-92.13	-14.12	-13.73	-4.51	-2.5	-2.37	-6.66	-0.47	-0.17	-0.37	-0.27
Price/Book Value Low	- -	- -	-0.15	-0.01	-0.54	-0.59	-0.24	-0.31	-0.57	-0.06	-0.03	-0.07	-0.01	-0.09	-0.01
Price/Tangible Book Value	- -	- -	-0.15	-0.01	-21.69	-4.07	-0.78	-1.31	-0.51	-0.1	-0.03	-0.07	-0.11	-0.11	-0.01
Price/Tangible Book Value Average	- -	- -	-0.15	-0.01	-23.66	-7.22	-4.21	-1.04	-1.11	-0.65	-0.45	-0.13	-0.08	-0.17	-0.04
Price/Tangible Book Value High	- -	- -	-0.15	-0.1	-92.13	-14.12	-13.73	-3.07	-1.87	-2.05	-5.65	-0.42	-0.16	-0.36	-0.27
Price/Tangible Book Value Low	- -	- -	-0.15	-0.01	-0.54	-0.59	-0.24	-0.21	-0.42	-0.06	-0.03	-0.06	-0.01	-0.09	-0.01
Price/Sales	- -	- -	- -	1.13	1,564.98	8,176.68	- -	- -	79.23	4.27	1.48	12.77	18.51	17.14	21.66
Price/Sales Average	- -	- -	- -	2.45	1,707.6	14,513.44	- -	- -	170.69	29.15	23.04	25.98	12.75	26.74	120.01
Price/Sales High	- -	- -	- -	18.53	6,648.04	28,383.35	- -	- -	287.75	91.95	287.35	81.85	25.71	55.18	725.67
Price/Sales Low	- -	- -	- -	0.91	38.81	1,180.75	- -	- -	65.3	2.47	1.47	11.54	1.03	13.79	21.66
Price/Cash Flow	- -	- -	-0.98	-0.1	-41.64	-34.21	-2.38	-4.7	-2.29	-0.52	-0.33	-0.95	-3.69	19.73	2.16
Price/Cash Flow Average	- -	- -	-0.98	-0.22	-45.43	-60.73	-12.79	-3.75	-4.94	-3.56	-5.15	-1.93	-2.54	30.77	11.99
Price/Cash Flow High	- -	- -	-0.98	-1.65	-176.87	-118.76	-41.72	-11.01	-8.32	-11.22	-64.24	-6.07	-5.13	63.49	72.53
Price/Cash Flow Low	- -	- -	-0.98	-0.08	-1.03	-4.94	-0.72	-0.74	-1.89	-0.3	-0.33	-0.86	-0.21	15.87	2.16
Price/Free Cash Flow Average	- -	- -	-1.82	-0.22	-45.43	-60.95	-12.79	1,095.71	-4.95	-3.56	-5.15	-1.93	-2.54	30.77	11.99
Price/Free Cash Flow High	- -	- -	-1.82	-1.65	-176.87	-119.21	-41.72	3,218.4	-8.35	-11.24	-64.24	-6.07	-5.13	63.49	72.53
Price/Free Cash Flow Low	- -	- -	-1.82	-0.08	-1.03	-4.96	-0.72	217.72	-1.89	-0.3	-0.33	-0.86	-0.21	15.87	2.16
EV/Sales Average	- -	24.19	- -	35.36	4,649.1	16,062.98	- -	- -	350.36	71.77	86.22	129.41	72.38	81.26	804.04
EV/Sales High	- -	24.19	- -	51.45	17,930.77	31,072.77	- -	- -	489.57	178.88	617.11	198.96	92.23	114.06	1,409.69
EV/Sales Low	- -	24.19	- -	33.82	162.8	1,634.55	- -	- -	225.02	26.28	42.89	111.42	54.42	66.33	705.68
EV/EBITDA Average	0.51	1,180.34	-0.33	-0.34	-51.7	-26.87	-7.05	-4.21	-8.31	-7.05	-6.32	-5.99	-3.74	-5.01	-8.58
EV/EBITDA High	0.51	1,180.34	-0.33	-0.49	-199.4	-51.97	-22.16	-10.41	-11.62	-17.56	-45.25	-9.22	-4.77	-7.04	-15.04
EV/EBITDA Low	0.51	1,180.34	-0.33	-0.32	-1.81	-2.73	-0.75	-1.65	-5.34	-2.58	-3.15	-5.16	-2.81	-4.09	-7.53
EV/EBIT Average	0.51	- -	-0.32	-0.33	-51.33	-26.71	-7.03	-4.2	-7.01	-5.84	-4.91	-4.25	-3	-3.9	-5.18
EV/EBIT High	0.51	- -	-0.32	-0.49	-197.96	-51.67	-22.09	-10.37	-9.8	-14.57	-35.13	-6.53	-3.82	-5.48	-9.08
EV/EBIT Low	0.51	- -	-0.32	-0.32	-1.8	-2.72	-0.75	-1.64	-4.5	-2.14	-2.44	-3.66	-2.26	-3.19	-4.54
Last Price	- -	- -	510	31	1,250	360.1	49.9	58	18.2	1.9	0.02	0.02	0.02	0.01	- -
High Price	- -	- -	510	510	5,310	1,250	875	136	66.1	40.9	3.9	0.1	0.02	0.03	0.01
Enterprise Value Average	- -	1	1	1	112	69	38	19	29	22	14	9	10	11	8
Enterprise Value High	- -	1	1	1	434	133	120	48	41	55	102	15	12	16	14
Enterprise Value Low	- -	1	1	1	4	7	4	8	19	8	7	8	7	9	7

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	25	74	213	319	544
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	12	60	139	276	544
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	12	60	139	276	544
Revenue per Share	130.57	102.95	- -	27.52	0.8	0.04	- -	- -	0.23	0.44	0.01	- -	- -	- -	- -
EBITDA per Share	-145.77	2.11	-3,171.46	-2,904.76	-71.83	-26.33	-45.95	-18.96	-9.68	-4.53	-0.19	-0.03	-0.02	-0.01	- -
Operating Income per Share	-147.84	- -	-3,240.55	-2,919.14	-72.35	-26.48	-46.09	-19.02	-11.47	-5.46	-0.24	-0.04	-0.02	-0.01	- -
Basic EPS, GAAP	-149.57	-202.78	-3,571.92	-3,476.92	-31.68	-69.86	-45.28	-44.65	-17.76	-24.83	-0.03	-0.05	-0.13	0.03	-0.01
Basic EPS from Cont Ops	-149.57	-202.78	-3,561.82	-3,476.92	-31.68	-69.86	-45.28	-44.65	-17.76	-24.83	-0.03	-0.05	-0.13	0.03	-0.01
Diluted EPS, GAAP	-149.57	-202.78	-3,571.92	-3,476.92	-31.68	-69.86	-45.28	-44.65	-17.76	-24.83	-0.03	-0.05	-0.13	0.03	-0.01
Diluted EPS from Cont Ops	-149.57	-202.78	-3,561.82	-3,476.92	-31.68	-69.86	-45.28	-44.65	-17.76	-24.83	-0.03	-0.05	-0.13	0.03	-0.01
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	18.32	-108.52	-521.41	-309.39	-30.02	-10.53	-20.97	-12.35	-7.94	-3.64	-0.06	-0.02	- -	- -	- -
Free Cash Flow per Basic Share	17.97	-108.52	-761.93	-309.39	-30.02	-10.57	-20.97	-24.74	-7.97	-3.65	-0.06	-0.02	- -	- -	- -
Cash & Equivalents per Share	74.94	20.35	1.49	3.91	0.01	0.4	0.41	0.28	0.88	0.02	- -	- -	- -	- -	- -
Book Value per Share	357.87	-963.85	-3,509.62	-4,966.6	-57.64	-88.51	-63.73	-30.13	-26.43	-17.24	-0.59	-0.21	-0.15	-0.08	-0.05
Tangible Book Value per Share	357.87	-3,084.81	-3,509.62	-4,981.03	-57.64	-88.51	-63.73	-44.33	-35.37	-19.94	-0.69	-0.24	-0.16	-0.08	-0.05

Endonovo Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)